(MedPage Today) -- What non-amyloid targets should be pursued for Alzheimer's disease therapies? We put the question to three well-known researchers in the field. Their answers ranged from tau protein pathologies to apolipoprotein E to general neuroprotection. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment